DRG1 and breast cancer: In the process of exploring the mechanism of transcriptional inactivation, the authors found that the DRG-1 gene has two potential CpG islands upstream of the transcription start site, and treatment with the demethylating agent 5-azacytidine increases DRG-1 expression, which revealed the role of methylation in promoting breast cancer bone metastasis [86].